EDGAR Filing Documents for 0001193125-22-145580

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-22-145580

Filing Date

2022-05-10

Accepted

2022-05-10 06:12:48

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1/A	d143161ds1a.htm	S-1/A	1383685
2	EX-1.1	d143161dex11.htm	EX-1.1	213936
3	EX-3.1	d143161dex31.htm	EX-3.1	41943
4	EX-3.2	d143161dex32.htm	EX-3.2	118274
5	EX-4.3	d143161dex43.htm	EX-4.3	40152
6	EX-4.4	d143161dex44.htm	EX-4.4	112055
7	EX-10.1	d143161dex101.htm	EX-10.1	37747
8	EX-10.3	d143161dex103.htm	EX-10.3	94586
9	EX-10.4	d143161dex104.htm	EX-10.4	40278
10	EX-10.5	d143161dex105.htm	EX-10.5	18808
11	EX-10.7	d143161dex107.htm	EX-10.7	11493
12	EX-10.8	d143161dex108.htm	EX-10.8	18923
13	EX-23.1	d143161dex231.htm	EX-23.1	1801
14	EX-FILING FEES	d143161dexfilingfees.htm	EX-FILING FEES	24803
15	GRAPHIC	g143161g25m25.jpg	GRAPHIC	99800
	Complete submission text file	0001193125-22-145580.txt		2297062

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004

Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700

Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)